Sarah M. Larson, MD

Sarah Larson, MD

Assistant Professor, Department of Medicine, Hematology/Oncology

Languages

English

Specialty

Hematology/Oncology

Institutional Affiliation

Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica

Education

Fellowships

Hematology and Medical Oncology, UCLA School of Medicine, 2011 - 2013
Hematology and Medical Oncology, University of Chicago Pritzker School of Medicine, 2010 - 2011

Internship

Internal Medicine, University of Chicago Pritzker School of Medicine, 2007 - 2008

Degree

MD, University of Minnesota Medical School, 2007

Residency

Internal Medicine, University of Chicago Pritzker School of Medicine, 2008 - 2010

Board Certifications

Hematology, American Board of Internal Medicine, 2013
Medical Oncology, American Board of Internal Medicine, 2013
Internal Medicine, American Board of Internal Medicine, 2010

Contact Information

Clinical Interests

Bone Marrow Transplant, Lymphoma, Multiple Myeloma

Scientific Interests

Dr. Sarah Larson is interested in identifying novel signal pathways and therapeutics for B cell lymphomas and multiple myeloma. She works with the lymphoma and multiple myeloma cell line panels in the Translational Oncology Research Laboratory (TORL) and conducts clinical trials as a member of the Hematologic Malignancies Program and the Lymphoma Program.

Highlighted Publications

Larson SM, Campbell NP, Huo D, Artz A, Zhang Y, Gajria D, Green M, Weiner H, Daugherty C, Odenike O, Godley LA, Hyjek E, Gurbuxani S, Thirman M, Sipkins D, Van Besien K, Larson RA, Stock W. High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML). Leuk Lymphoma. 2012 Mar;53(3):445-50. doi: 10.3109/10428194.2011.621562.

Larson SM, Godley LA. Getting to the root of the stem cell in mutated chronic myeloid leukemia. Leuk Lymphoma. 2010 Dec;51(12):2147-8. doi: 10.3109/10428194.2010.531802.

In the News

View more articles